Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting

Abstract Human Ku70/Ku80 protein is known to influence HIV-1 replication. One of the possible reasons may be the protection of integrase from proteasomal degradation by Ku70 subunit. We demonstrated that recombinant HIV-1 integrase and Ku70 form a stable complex, while no interaction of Ku70 with in...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Andrey N. Anisenko, Ekaterina S. Knyazhanskaya, Artur O. Zalevsky, Julia Yu Agapkina, Aleksander I. Sizov, Timofey S. Zatsepin, Marina B. Gottikh
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c745e5f6f43046aebb85df84c70d8236
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c745e5f6f43046aebb85df84c70d8236
record_format dspace
spelling oai:doaj.org-article:c745e5f6f43046aebb85df84c70d82362021-12-02T16:08:21ZCharacterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting10.1038/s41598-017-05659-52045-2322https://doaj.org/article/c745e5f6f43046aebb85df84c70d82362017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05659-5https://doaj.org/toc/2045-2322Abstract Human Ku70/Ku80 protein is known to influence HIV-1 replication. One of the possible reasons may be the protection of integrase from proteasomal degradation by Ku70 subunit. We demonstrated that recombinant HIV-1 integrase and Ku70 form a stable complex, while no interaction of Ku70 with integrase from prototype foamy virus was observed. By analyzing protein subdomains we determined two binding sites in the structure of both Ku70 and integrase: the 51–160 a.a. region of integrase interacts with residues 251–438 of Ku70, whereas Ku70 N-terminal domain (1–250 a.a.) contacts an α6-helix in the 200–220 a.a. integrase region. Single substitutions within integrase (E212A or L213A) block the interaction with Ku70 thus indicating that the binding site formed by the 200–220 a.a. integrase region is crucial for complex formation. E212A/L213A substitutions decreased the integrase capacity to bind Ku70 in HEK293T cells. A conjugate of 2′-ОMe-GGUUUUUGUGU oligonucleotide with eosin is shown by molecular modeling to shield integrase residues E212/L213 and is effective in blocking complex formation of Ku70 with integrase what makes the complex between α6-helix and Ku70(1–250) a possible target for drug development.Andrey N. AnisenkoEkaterina S. KnyazhanskayaArtur O. ZalevskyJulia Yu AgapkinaAleksander I. SizovTimofey S. ZatsepinMarina B. GottikhNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-14 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Andrey N. Anisenko
Ekaterina S. Knyazhanskaya
Artur O. Zalevsky
Julia Yu Agapkina
Aleksander I. Sizov
Timofey S. Zatsepin
Marina B. Gottikh
Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting
description Abstract Human Ku70/Ku80 protein is known to influence HIV-1 replication. One of the possible reasons may be the protection of integrase from proteasomal degradation by Ku70 subunit. We demonstrated that recombinant HIV-1 integrase and Ku70 form a stable complex, while no interaction of Ku70 with integrase from prototype foamy virus was observed. By analyzing protein subdomains we determined two binding sites in the structure of both Ku70 and integrase: the 51–160 a.a. region of integrase interacts with residues 251–438 of Ku70, whereas Ku70 N-terminal domain (1–250 a.a.) contacts an α6-helix in the 200–220 a.a. integrase region. Single substitutions within integrase (E212A or L213A) block the interaction with Ku70 thus indicating that the binding site formed by the 200–220 a.a. integrase region is crucial for complex formation. E212A/L213A substitutions decreased the integrase capacity to bind Ku70 in HEK293T cells. A conjugate of 2′-ОMe-GGUUUUUGUGU oligonucleotide with eosin is shown by molecular modeling to shield integrase residues E212/L213 and is effective in blocking complex formation of Ku70 with integrase what makes the complex between α6-helix and Ku70(1–250) a possible target for drug development.
format article
author Andrey N. Anisenko
Ekaterina S. Knyazhanskaya
Artur O. Zalevsky
Julia Yu Agapkina
Aleksander I. Sizov
Timofey S. Zatsepin
Marina B. Gottikh
author_facet Andrey N. Anisenko
Ekaterina S. Knyazhanskaya
Artur O. Zalevsky
Julia Yu Agapkina
Aleksander I. Sizov
Timofey S. Zatsepin
Marina B. Gottikh
author_sort Andrey N. Anisenko
title Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting
title_short Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting
title_full Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting
title_fullStr Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting
title_full_unstemmed Characterization of HIV-1 integrase interaction with human Ku70 protein and initial implications for drug targeting
title_sort characterization of hiv-1 integrase interaction with human ku70 protein and initial implications for drug targeting
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c745e5f6f43046aebb85df84c70d8236
work_keys_str_mv AT andreynanisenko characterizationofhiv1integraseinteractionwithhumanku70proteinandinitialimplicationsfordrugtargeting
AT ekaterinasknyazhanskaya characterizationofhiv1integraseinteractionwithhumanku70proteinandinitialimplicationsfordrugtargeting
AT arturozalevsky characterizationofhiv1integraseinteractionwithhumanku70proteinandinitialimplicationsfordrugtargeting
AT juliayuagapkina characterizationofhiv1integraseinteractionwithhumanku70proteinandinitialimplicationsfordrugtargeting
AT aleksanderisizov characterizationofhiv1integraseinteractionwithhumanku70proteinandinitialimplicationsfordrugtargeting
AT timofeyszatsepin characterizationofhiv1integraseinteractionwithhumanku70proteinandinitialimplicationsfordrugtargeting
AT marinabgottikh characterizationofhiv1integraseinteractionwithhumanku70proteinandinitialimplicationsfordrugtargeting
_version_ 1718384558261403648